QNTM ▲ +3.1% - Quantum BioPharma Ltd. $QNTM - Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment Quantum BioPharma rose 3.1% following FDA clearance to initiate clinical trials for a new multiple sclerosis treatment. The regulatory approval to advance the company's MS candidate into human testing represents a significant development milestone and likely triggered investor optimism about the therapeutic's potential commercial pathway. 09-SEP-2026 08:30 AM ET